Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC

NCT03732781 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Peritoneal Carcinoma
Colorectal Carcinoma

Interventions

DRUG: Radspherin

Sponsor

Oncoinvent Solutions AS